ToxChats©
By ACT ToxChats
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Image by ACT ToxChats
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 7
Reviews: 0
Episodes: 53
Description
The American College of Toxicology podcast program, ToxChats ©, reports on cutting-edge news in toxicological research from around the globe.
| Episode | Date |
|---|---|
|
Infectious Disease Outbreaks and Disease Elimination in the 21st Century: Reflections from the 2025 ACT Plenary Speaker
|
Sep 22, 2026 |
|
Weight of Evidence Approach to Carcinogenicity: An Interview with Todd Bourcier and Tim McGovern
|
Jul 31, 2026 |
|
Next-Gen Toxicology: Inside the Organ Chip Revolution with Dr. Donald Ingber
|
May 01, 2026 |
|
Transitioning from Industry to Consulting, Independent vs. Firm Consultant
|
Feb 27, 2026 |
|
Human and Environmental Health Topic: Next Generation Risk Assessment
|
Nov 07, 2025 |
|
The Science of Mentorship: A Conversation with Richard DiMarchi
|
Oct 15, 2025 |
|
From RIF to Reboot: A Guide for Early to Mid-Career Toxicologists
|
Sep 30, 2025 |
|
Discussing the FDA's Announcement to Phase Out Animal Testing in Monoclonal Antibody Development
|
Jul 17, 2025 |
|
Specialty Tox Topic: In Vivo Dermal Drug Development
|
Jul 07, 2025 |
|
Specialty Tox Topic: In Vitro Dermal Drug Development
|
Jun 23, 2025 |
|
Occupational Toxicology and Product Quality: Navigating Impurities and Occupational Safety
|
May 05, 2025 |
|
The Past, Present, and Future of Safety Pharmacology
|
Apr 01, 2025 |
|
Career Path: Toxicologist in the Food Industry
|
Feb 03, 2025 |
|
Changing Approaches to Getting Drug Candidates into First-in-Human Clinical Trials: A Case Study
|
Dec 18, 2024 |
|
Career Path: Pharmaceutical Consultant in the Field of Toxicology
|
Nov 04, 2024 |
|
3D Printing Emissions and Potential Health Effects from a Consumer Perspective
|
Sep 02, 2024 |
|
Career Path: Pharmaceutical Consultant in the Field of Occupational, Environmental, and Quality Toxicology
|
Aug 16, 2024 |
|
Discussions on Identifying Seizures Liability in Nonclinical Studies
|
Jul 01, 2024 |
|
Alternative and Nontraditional Species Series: The Use of Transgenic and Disease Mouse Animal Models for Toxicology Studies
|
May 06, 2024 |
|
Identifying an Appropriate Sponsor to Support Your Growth and Success in the Workplace
|
Mar 04, 2024 |
|
Alternative and Nontraditional Species Series: Fertilized Egg Model as an Alternative Species for Safety Assessment Studies
|
Jan 29, 2024 |
|
Alternative and Nontraditional Species Series: Advantages and Challenges of Using Rabbits
|
Jan 22, 2024 |
|
Alternative and Nontraditional Species Series: Sheep as an Alternative Model for the Safety Evaluation of Medical Devices
|
Jan 15, 2024 |
|
Alternative and Nontraditional Species Series: Mini Pig–Alternatives to Traditional Nonrodent Models in Nonclinical Safety Testing
|
Jan 08, 2024 |
|
Medical Devices: Safety Evaluation and Becoming a Medical Device Toxicologist
|
Nov 28, 2023 |
|
Interviewing and Negotiation 101 for Toxicologist Roles in the Biopharmaceutical Industry
|
Sep 05, 2023 |
|
The History and Future of Oligonucleotide Drug Development
|
Jul 05, 2023 |
|
The Opioid Crisis: Misconceptions, History, and Interventions
|
Apr 28, 2023 |
|
Covid-19 Part 2: New Type of Antibody-Dependent Enhancement Associated with SARS-CoV-2 Virus: MIS-C, MIS-A, and MIS-N
|
Mar 03, 2023 |
|
Covid-19 Part 1: Antibody-dependent Enhancement of Disease
|
Jan 06, 2023 |
|
Artificial Intelligence (AI) Use in Toxicology
|
Nov 03, 2022 |
|
Overview of mRNA Vaccines
|
Sep 08, 2022 |
|
Tips for Taking the ABT Exam
|
Jun 16, 2022 |
|
Moving from Minion to Manager
|
May 26, 2022 |
|
Off the Beaten Path: The Nonclinical Development of Gene Therapy Products to Cure Monogenic Diseases
|
Mar 24, 2022 |
|
Digital Pathology
|
Jan 20, 2022 |
|
Expedited FDA Programs
|
Jun 17, 2021 |
|
Toxicology Salary Survey
|
May 13, 2021 |
|
Pediatric Drug Development
|
Mar 04, 2021 |
|
CAR/T: New Modalities Paving the Way for Cancer
|
Jan 06, 2021 |
|
History and Risk Assessment of Vaccines—Q&A
|
Nov 05, 2020 |
|
Scientific Communication: Distilling and Rehearsing to Reach Your Audience
|
Aug 20, 2020 |
|
AI and Big Data for Safety Testing
|
Apr 27, 2020 |
|
Shining a Light on the Science and Strategy of Phototoxicity Assessments
|
Apr 10, 2020 |
|
The Twists and Turns of GI Health and Medicine: An Interview with Dr. Alessio Fasano
|
Feb 10, 2020 |
|
The Scientific Approach to Address Uncommon Routes and Best Practices for Forming a Working Group
|
Oct 03, 2019 |
|
CRISPR Then and Now: An Interview with Dr. Jacob Corn, ACT 2015 Plenary Speaker
|
Aug 16, 2019 |
|
In Vitro and Alternative Models for Regulatory Submission
|
Nov 30, 2018 |
|
Regulation of E-Cigarettes
|
Jul 19, 2018 |
|
The Opioid Epidemic
|
Apr 26, 2018 |
|
Biomarkers
|
Sep 27, 2017 |
|
Microbiome
|
Jun 27, 2017 |
|
Oligonucleotide Therapeutics
|
May 05, 2017 |